Submitted by Anonymous (not verified) on 24 July 2025 - 14:18
Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised